ERGOMED is a European clinical development company providing consultancy and full clinical trial-related services. ERGOMED can provide also post-marketing services such as Phase IV/observational studies, pharmacovigilance, and medical affairs. In addition, ERGOMED has access to its own Phase I unit for special patient populations and early phase oncology studies.

ERGOMED can also enter co-development partnerships that share the risks and rewards of clinical development.

We conduct operations in the MENA region (Middle East and North Africa), North America and throughout Europe and with special focus on Western, Central and Eastern European countries.